Kerry Watts
Kerry Watts is Founder and Director of Kaplar Consultancy, a FANZCAP-accredited consultant pharmacist (Compound., Research), and a PhD candidate at the University of Sydney, with expertise in advanced therapeutics, precision medicine, regulatory affairs, and GMP. Kerry’s work focuses on health system preparedness for emerging therapies, including pharmacogenomics, gene and cell therapies, and bacteriophage therapy. She works across government, academic, and clinical sectors to support the translation of innovative therapies into practice through workforce development, regulatory guidance, and implementation science.
Abstracts this author is presenting: